The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Microglia and Monocytes/Macrophages Polarization Reveal Novel Therapeutic Mechanism against Stroke
Open accessAbstract
Stroke is a leading cause of morbidity and mortality worldwide, and consists of two types, ischemic and hemorrhagic. Currently, there is no effective treatment to increase the survival rate or improve the quality of life after ischemic and hemorrhagic stroke in the subacute to chronic phases. Therefore, it is necessary to establish therapeutic strategies to facilitate functional recovery in patients with stroke during both phases. Cell-based therapies, using microglia and monocytes/macrophages preconditioned by optimal stimuli and/or any therapies targeting these cells, might be an ideal therapeutic strategy for managing stroke. Microglia and monocytes/macrophages polarize to the classic pro-inflammatory type (M1-like) or alternative protective type (M2-like) by optimal condition. Cell-based therapies using M2-like microglia and monocytes/macrophages might be protective therapeutic strategies against stroke for three reasons. First, M2-like microglia and monocytes/monocytes secrete protective remodeling factors, thus prompting neuronal network recovery via tissue (including neuronal) and vascular remodeling. Second, these cells could migrate to the injured hemisphere through the blood–brain barrier or choroid–plexus. Third, these cells could mitigate the extent of inflammation-induced injuries by suitable timing of therapeutic intervention. Although future translational studies are required, M2-like microglia and monocytes/macrophages therapies are attractive for managing stroke based on their protective functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 1×
“In addition, microglia and monocytes/macrophages might be categorized into four main states, namely the (1) classically activated M1-microglia with cytotoxic properties, (2) M2a-microglia with an alternate activation, which is involved in repair and regeneration, (3) M2b-microglia with an immunoregulatory phenotype, a…”
BackgroundPolazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Goyal, M., Menon, B. K., van Zwam, W. H., Dippel, D. W. J., Mitchell, P. J., Demchuk, A. M., Dávalos, A., Majoie, C. B. L. M., van der Lugt, A., de Miquel, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00163-x · Cited by 7,815
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175 · cited 2×
“, CD11b, F4/80, Iba-1) and share similar functions [40], including fundamental functions, such as phagocytosis and modulation of inflammation.”
BackgroundMicroglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · cited 1×
“However, they have also been demonstrated to exert a protective role in processes involved in neurological recovery, including neurogenesis, axonal outgrowth, synaptogenesis, angiogenesis, oligodendrogenesis, and remyelination in several CNS diseases [45,46].”
BackgroundWinstein, C. J., Stein, J., Arena, R., Bates, B., Cherney, L. R., Cramer, S. C., Deruyter, F., Eng, J. J., Fisher, B., Harvey, R. L., et al. (2016) · Stroke · doi:10.1161/str.0000000000000098 · Cited by 3,293
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245 · cited 3×
“Microglia originate from yolk sac progenitors in the neuroepithelium, and express, in the adult brain, high levels of CX3C chemokine receptor 1 (CX3CR1), cluster of differentiation 11b (CD11b), and F4/80, low levels of CD45, and no C-C chemokine receptor type 2 (CCR2) [35].”
BackgroundFeigin, V. L., Lawes, C. M., Bennett, D. A., Barker-Collo, S. L., & Parag, V. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70025-0 · Cited by 2,855 · cited 1×
“The majority (70–80%) of stroke cases is ischemic, while intracerebral hemorrhage accounts only for 10–20% of all stroke cases [1].”
BackgroundThe immunology of stroke: from mechanisms to translation
Iadecola, C., & Anrather, J. (2011) · Nature Medicine · doi:10.1038/nm.2399 · Cited by 2,596 · cited 6×
“After stroke, the release of nucleotides (ATP, UTP) from injured cells, including neurons, activates purinergic receptors on microglia and monocytes/macrophages, and leads to the production of pro-inflammatory cytokines [17].”
BackgroundInfluentialIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“Recently, the purinergic receptor P2Y12 (P2Y12R) has been identified as a specific marker for microglia in rodents, thus enabling their distinction from monocytes/macrophages [37].”
Background
Cited by
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
Zhang, M., Liu, Q., Meng, H., Duan, H., Liu, X., Wu, J., Gao, F., Wang, S., Tan, R., & Yuan, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01688-x · Cited by 712
Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death
Kapralov, A. A., Yang, Q., Dar, H. H., Tyurina, Y. Y., Anthonymuthu, T. S., Kim, R., St. Croix, C. M., Mikulska-Ruminska, K., Liu, B., Shrivastava, I. H., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-019-0462-8 · Cited by 650
Glial Cells: Role of the Immune Response in Ischemic Stroke
Xu, S., Lu, J., Shao, A., Zhang, J. H., & Zhang, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00294 · Cited by 601
Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression
Wang, H., He, Y., Sun, Z., Ren, S., Liu, M., Wang, G., & Yang, J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02492-0 · Cited by 571
Jurcau, A., & Simion, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010014 · Cited by 500
Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets
Tschoe, C., Bushnell, C. D., Duncan, P. W., Alexander-Miller, M. A., & Wolfe, S. Q. (2020) · Journal of Stroke · doi:10.5853/jos.2019.02236 · Cited by 490
Feng, L., Dou, C., Xia, Y., Li, B., Zhao, M., Yu, P., Zheng, Y., El-Toni, A. M., Atta, N. F., Galal, A., et al. (2021) · ACS Nano · doi:10.1021/acsnano.0c07973 · Cited by 372
Interleukins and Ischemic Stroke
Zhu, H., Hu, S., Li, Y., Sun, Y., Xiong, X., Hu, X., Chen, J., & Qiu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.828447 · Cited by 363
Microglia Phenotypes in Aging and Neurodegenerative Diseases
Wendimu, M. Y., & Hooks, S. B. (2022) · Cells · doi:10.3390/cells11132091 · Cited by 336
Angiogenesis and neuronal remodeling after ischemic stroke
Kanazawa, M., Hatakeyama, M., & Ninomiya, I. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.264442 · Cited by 328
Self-citationJiang, D., Gong, F., Ge, X., Lv, C., Huang, C., Feng, S., Zhou, Z., Rong, Y., Wang, J., Ji, C., et al. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00665-8 · Cited by 282
“M1 microglia is considered pro-inflammatory and increase the secretion of inflammatory cytokines [7, 8].”
BackgroundXu, X., Gao, W., Li, L., Hao, J., Yang, B., Wang, T., Li, L., Bai, X., Li, F., Ren, H., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02174-3 · Cited by 274
Zhang, Y., Xing, Z., Zhou, K., & Jiang, S. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s339221 · Cited by 256
Zeng, J., Bao, T., Yang, K., Zhu, X., Wang, S., Xiang, W., Ge, A., Zeng, L., & Ge, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1047550 · Cited by 175
TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury
Wei, W., Zhang, L., Xin, W., Pan, Y., Tatenhorst, L., Hao, Z., Gerner, S. T., Huber, S., Juenemann, M., Butz, M., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115962 · Cited by 122
NAMPT: A pleiotropic modulator of monocytes and macrophages
Travelli, C., Colombo, G., Mola, S., Genazzani, A. A., & Porta, C. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.022 · Cited by 91
Barca, C., Foray, C., Hermann, S., Herrlinger, U., Remory, I., Laoui, D., Schäfers, M., Grauer, O. M., Zinnhardt, B., & Jacobs, A. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.787307 · Cited by 64
Zhu, C., Wang, D., Chang, C., Liu, A., Zhou, J., Yang, T., Jiang, Y., Li, X., & Jiang, W. (2024) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2024.28.3.239 · Cited by 21
Huang, Y., Li, K., Dai, Q., Pang, H., Xu, Z., Luo, X., & Liu, L. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176033 · Cited by 4
Metadata
- Authors
- Kanazawa, M., Ninomiya, I., Hatakeyama, M., Takahashi, T., & Shimohata, T.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-10-13
- Volume
- 18
- Issue
- 10
- Pages
- 2135
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2761635843
- Cited by
- 398
- References
- 125
- FWCI
- 13.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.